Prediction of Postoperative Intravesical Recurrence Using Urine <scp>DNA</scp> Monitoring in Nonmuscular‐Invasive Urothelial Bladder Cancer
Urine DNA as screened by our genomic panel may be useful for predicting and detecting intravesical recurrence in UBC. The simultaneous evaluation of urine precipitation and supernatant may enhance the clinical utility of urine DNA during surveillance for intravesical recurrence in UBC patients.
Authors
- Yosuke Hirotsu (ORCID: https://orcid.org/0000-0002-8002-834X)
- Tomonori Minagawa (ORCID: https://orcid.org/0000-0002-5910-2808)
- Masao Omata (ORCID: https://orcid.org/0000-0001-7977-1497)
- Masashi Shiozaki (ORCID: https://orcid.org/0000-0001-9063-782X)
- Hitoshi Yokoyama (ORCID: https://orcid.org/0000-0003-4821-9506)
- Yoshiyuki Akiyama (ORCID: https://orcid.org/0000-0003-1439-5640)
- Toshio Oyama
Institutions
- Shinshu University (JP)
- Yamanashi Prefectural Central Hospital (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- International Journal of Urology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1111/iju.70293
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Yasuda Memorial Medical Foundation
- Japan Society for the Promotion of Science